Report 5 figures and tables: Economic Burden of Illness in Canada, 2005–2008

Report 5: EBIC Value of Lost Production due to Morbidity, 2005-2010

Figures and Tables

Table 15: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2010
($' 000,000 Current Dollars)
Diagnostic Category Male Cost Female Cost Age 15-54 years Cost Age 55-75 years Cost Total Cost
*High sampling variability
**Very high sampling variability
Note: Any discrepancies may be due to rounding.
Certain Infectious and Parasitic Diseases 423.6 436.2 750.1 109.7 Table 15 - Footnote * 859.8
Respiratory Infections 1,555.0 1,349.0 2,530.8 373.2 2,904.0
Malignant Neoplasms 402.7 Table 15 - Footnote ** 126.3 Table 15 - Footnote * 300.6 Table 15 - Footnote ** 228.4 Table 15 - Footnote * 529.1 Table 15 - Footnote *
Diabetes Mellitus 140.6 Table 15 - Footnote ** 18.1 Table 15 - Footnote ** 53.5 Table 15 - Footnote * 105.2 Table 15 - Footnote ** 158.6 Table 15 - Footnote *
Neuropsychiatric Conditions 623.5 625.8 1,118.9 130.4 Table 15 - Footnote * 1,249.3
Cardiovascular Diseases 226.5 Table 15 - Footnote * 74.3 Table 15 - Footnote * 205.9 Table 15 - Footnote ** 94.9 Table 15 - Footnote * 300.8 Table 15 - Footnote *
Respiratory Diseases 66.1 Table 15 - Footnote * 51.6 Table 15 - Footnote * 78.9 Table 15 - Footnote * 38.7 Table 15 - Footnote * 117.6
Digestive Diseases 120.2 Table 15 - Footnote * 49.2 Table 15 - Footnote * 102.1 Table 15 - Footnote * 67.4 Table 15 - Footnote ** 169.5 Table 15 - Footnote *
Genitourinary Diseases 180.2 Table 15 - Footnote ** 40.4 Table 15 - Footnote ** 209.7 Table 15 - Footnote ** 10.9 Table 15 - Footnote ** 220.6 Table 15 - Footnote *
Musculoskeletal Diseases 764.3 761.3 1,248.6 277.1 1,525.6
Injuries 2,281.4 942.8 2,468.3 755.9 3,224.2
Unattributable 2,969.8 3,935.2 5,788.8 1,116.2 6,905.0
Total 9,753.8 8,410.3 14,856.2 3,307.8 18,164.1

Table 16: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2009
($' 000,000 Current Dollars)
Diagnostic Category Male Cost Female Cost Age 15-54 years Cost Age 55-75 years Cost Total Cost
*High sampling variability
**Very high sampling variability
Note: Any discrepancies may be due to rounding.
Certain Infectious and Parasitic Diseases 406.9 421.1 726.6 101.3 Table 16 - Footnote * 827.9
Respiratory Infections 1,494.3 1,322.0 2,464.0 352.3 2,816.3
Malignant Neoplasms 358.2 Table 16 - Footnote ** 111.4 Table 16 - Footnote * 274.8 Table 16 - Footnote ** 194.8 Table 16 - Footnote * 469.6 Table 16 - Footnote *
Diabetes Mellitus 120.9 Table 16 - Footnote ** 17.5 Table 16 - Footnote ** 51.5 Table 16 - Footnote * 86.9 Table 16 - Footnote ** 138.4 Table 16 - Footnote *
Neuropsychiatric Conditions 549.4 568.4 1,003.8 114.1 Table 16 - Footnote * 1,117.9
Cardiovascular Diseases 205.2 Table 16 - Footnote * 68.8 Table 16 - Footnote * 189.1 Table 16 - Footnote ** 84.9 Table 16 - Footnote * 274.1 Table 16 - Footnote *
Respiratory Diseases 61.7 Table 16 - Footnote * 50.2 Table 16 - Footnote * 77.2 Table 16 - Footnote * 34.7 Table 16 - Footnote * 111.8
Digestive Diseases 107.7 Table 16 - Footnote * 47.4 Table 16 - Footnote * 99.2 Table 16 - Footnote * 55.8 Table 16 - Footnote ** 155.1 Table 16 - Footnote *
Genitourinary Diseases 141.1 Table 16 - Footnote ** 32.7 Table 16 - Footnote ** 163.8 Table 16 - Footnote ** 10.0 Table 16 - Footnote ** 173.8 Table 16 - Footnote *
Musculoskeletal Diseases 713.0 720.4 1,184.0 249.4 1,433.4
Injuries 2,105.0 887.5 2,313.1 679.4 2,992.5
Unattributable 2,740.5 3,702.3 5,420.6 1,022.2 6,442.8
Total 9,003.8 7,949.7 13,967.8 2,985.8 16,953.6

Table 17: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2008
($' 000,000 Current Dollars)
Diagnostic Category Male Cost Female Cost Age 15-54 years Cost Age 55-75 years Cost Total Cost
*High sampling variability
**Very high sampling variability
Note: Any discrepancies may be due to rounding.
Certain Infectious and Parasitic Diseases 418.6 408.3 732.3 94.6 Table 17 - Footnote * 826.9
Respiratory Infections 1,537.7 1,274.8 2,483.4 329.0 2,812.4
Malignant Neoplasms 325.2 Table 17 - Footnote ** 94.8 Table 17 - Footnote * 248.6 Table 17 - Footnote ** 171.4 Table 17 - Footnote * 420.0 Table 17 - Footnote *
Diabetes Mellitus 116.1 Table 17 - Footnote ** 16.8 Table 17 - Footnote ** 51.7 Table 17 - Footnote * 81.2 Table 17 - Footnote ** 132.9 Table 17 - Footnote *
Neuropsychiatric Conditions 511.8 512.5 927.9 96.5 Table 17 - Footnote * 1,024.4
Cardiovascular Diseases 206.3 Table 17 - Footnote * 63.3 Table 17 - Footnote * 194.1 Table 17 - Footnote ** 75.5 Table 17 - Footnote * 269.6 Table 17 - Footnote *
Respiratory Diseases 61.6 Table 17 - Footnote * 48.4 Table 17 - Footnote * 76.8 Table 17 - Footnote * 33.2 Table 17 - Footnote * 110.0
Digestive Diseases 105.6 Table 17 - Footnote * 45.5 Table 17 - Footnote * 98.6 Table 17 - Footnote * 52.5 Table 17 - Footnote ** 151.1 Table 17 - Footnote *
Genitourinary Diseases 129.3 Table 17 - Footnote ** 27.3 Table 17 - Footnote ** 145.1 Table 17 - Footnote ** 11.5 Table 17 - Footnote ** 156.5 Table 17 - Footnote *
Musculoskeletal Diseases 713.0 682.5 1,177.3 218.2 1,395.5
Injuries 2,081.7 827.3 2,290.8 618.2 2,909.0
Unattributable 2,715.6 3,472.4 5,257.2 930.9 6,188.1
Total 8,922.5 7,473.9 13,683.8 2,712.6 16,396.4

Table 18: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2007
($' 000,000 Current Dollars)
Diagnostic Category Male Cost Female Cost Age 15-54 years Cost Age 55-75 years Cost Total Cost
*High sampling variability
**Very high sampling variability
Note: Any discrepancies may be due to rounding.
Certain Infectious and Parasitic Diseases 389.4 388.2 692.7 85.0 Table 18 - Footnote * 777.6
Respiratory Infections 1,422.8 1,215.5 2,338.8 299.5 2,638.3
Malignant Neoplasms 331.7 Table 18 - Footnote ** 89.5 Table 18 - Footnote * 254.7 Table 18 - Footnote ** 166.5 Table 18 - Footnote * 421.2 Table 18 - Footnote *
Diabetes Mellitus 117.4 Table 18 - Footnote ** 16.2 Table 18 - Footnote ** 48.9 Table 18 - Footnote * 84.7 Table 18 - Footnote ** 133.6 Table 18 - Footnote *
Neuropsychiatric Conditions 487.0 493.5 891.9 88.6 Table 18 - Footnote * 980.5
Cardiovascular Diseases 197.4 Table 18 - Footnote * 58.7 Table 18 - Footnote * 188.6 Table 18 - Footnote ** 67.5 Table 18 - Footnote * 256.2 Table 18 - Footnote *
Respiratory Diseases 58.0 Table 18 - Footnote * 46.3 Table 18 - Footnote * 73.5 Table 18 - Footnote * 30.8 Table 18 - Footnote * 104.3
Digestive Diseases 104.5 Table 18 - Footnote * 44.4 Table 18 - Footnote * 94.0 Table 18 - Footnote * 54.9 Table 18 - Footnote ** 148.9 Table 18 - Footnote *
Genitourinary Diseases 125.8 Table 18 - Footnote ** 26.8 Table 18 - Footnote ** 143.8 Table 18 - Footnote ** 8.8 Table 18 - Footnote ** 152.7 Table 18 - Footnote *
Musculoskeletal Diseases 677.4 644.1 1,117.0 204.5 1,321.5
Injuries 1,950.3 797.7 2,160.9 587.0 2,748.0
Unattributable 2,570.5 3,359.4 5,074.6 855.4 5,930.0
Total 8,432.4 7,180.4 13,079.3 2,533.4 15,612.7

Table 19: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2006
($' 000,000 Current Dollars)
Diagnostic Category Male Cost Female Cost Age 15-54 years Cost Age 55-75 years Cost Total Cost
*High sampling variability
**Very high sampling variability
Note: Any discrepancies may be due to rounding.
Certain Infectious and Parasitic Diseases 372.6 366.7 659.9 79.4 Table 19 - Footnote * 739.3
Respiratory Infections 1,354.3 1,143.4 2,216.2 281.5 2,497.7
Malignant Neoplasms 323.5 Table 19 - Footnote ** 87.4 Table 19 - Footnote * 249.3 Table 19 - Footnote ** 161.6 Table 19 - Footnote * 410.9 Table 19 - Footnote *
Diabetes Mellitus 114.8 Table 19 - Footnote ** 15.5 Table 19 - Footnote ** 47.0 Table 19 - Footnote * 83.3 Table 19 - Footnote ** 130.3 Table 19 - Footnote *
Neuropsychiatric Conditions 486.7 482.7 883.8 85.7 Table 19 - Footnote * 969.5
Cardiovascular Diseases 184.4 Table 19 - Footnote * 56.5 Table 19 - Footnote * 176.0 Table 19 - Footnote ** 64.9 Table 19 - Footnote * 240.9 Table 19 - Footnote *
Respiratory Diseases 52.5 Table 19 - Footnote * 43.5 Table 19 - Footnote * 67.9 Table 19 - Footnote * 28.1 Table 19 - Footnote * 96.0
Digestive Diseases 99.6 Table 19 - Footnote * 42.3 Table 19 - Footnote * 87.5 Table 19 - Footnote * 54.4 Table 19 - Footnote ** 141.9 Table 19 - Footnote *
Genitourinary Diseases 123.1 Table 19 - Footnote ** 27.4 Table 19 - Footnote ** 142.8 Table 19 - Footnote ** 7.6 Table 19 - Footnote ** 150.5 Table 19 - Footnote *
Musculoskeletal Diseases 656.5 607.4 1,060.0 203.9 1,263.9
Injuries 1,902.9 757.0 2,085.6 574.2 2,659.8
Unattributable 2,490.8 3,218.6 4,902.6 806.7 5,709.4
Total 8,161.6 6,848.4 12,578.5 2,431.5 15,010.0

Table 20: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2005
($' 000,000 Current Dollars)
Diagnostic Category Male Cost Female Cost Age 15-54 years Cost Age 55-75 years Cost Total Cost
*High sampling variability
**Very high sampling variability
Note: Any discrepancies may be due to rounding.
Certain Infectious and Parasitic Diseases 359.5 352.8 638.8 73.6 Table 20 - Footnote * 712.4
Respiratory Infections 1,304.7 1,096.7 2,141.5 259.9 2,401.4
Malignant Neoplasms 307.8 Table 20 - Footnote ** 86.9 Table 20 - Footnote * 245.1 Table 20 - Footnote ** 149.6 Table 20 - Footnote * 394.7 Table 20 - Footnote *
Diabetes Mellitus 106.5 Table 20 - Footnote ** 15.8 Table 20 - Footnote ** 45.7 Table 20 - Footnote * 76.7 Table 20 - Footnote ** 122.3 Table 20 - Footnote *
Neuropsychiatric Conditions 488.8 466.2 868.6 86.4 Table 20 - Footnote * 955.0
Cardiovascular Diseases 181.1 Table 20 - Footnote * 53.4 Table 20 - Footnote * 175.5 Table 20 - Footnote ** 59.0 Table 20 - Footnote * 234.5 Table 20 - Footnote *
Respiratory Diseases 51.5 Table 20 - Footnote * 41.2 Table 20 - Footnote * 65.3 Table 20 - Footnote * 27.4 Table 20 - Footnote * 92.7
Digestive Diseases 94.4 Table 20 - Footnote * 39.2 Table 20 - Footnote * 83.6 Table 20 - Footnote * 50.0 Table 20 - Footnote ** 133.6 Table 20 - Footnote *
Genitourinary Diseases 128.6 Table 20 - Footnote ** 31.2 Table 20 - Footnote ** 151.9 Table 20 - Footnote ** 7.9 Table 20 - Footnote ** 159.8 Table 20 - Footnote *
Musculoskeletal Diseases 631.0 579.2 1,021.1 189.1 1,210.2
Injuries 1,833.1 720.2 2,026.8 526.5 2,553.3
Unattributable 2,418.4 3,087.0 4,746.0 759.4 5,505.3
Total 7,905.5 6,569.8 12,209.8 2,265.4 14,475.2

Table 21: Value of Lost Production due to Morbidity by Age Group, Canada, 2005-2010
($' 000,000 Current Dollars)
Age Group 2010 % of Total Cost 2009 % of Total Cost 2008 % of Total Cost 2007 % of Total Cost 2006 % of Total Cost 2005 % of Total Cost
15-34 years 4,135.7 23 3,846.1 23 3,771.2 23 3,485.8 22 3,377.2 22 3,250.4 22
35-54 years 10,720.5 59 10,121.6 60 9,912.5 60 9,593.6 61 9,201.2 61 8,959.4 62
55-64 years 3,107.4 17 2,809.1 17 2,546.2 16 2,382.6 15 2,301.2 15 2,139.1 15
65-75 years 200.4 1 176.7 1 166.4 1 150.8 1 130.3 1 126.3 1
Total Cost 18,164.1 100 16,953.6 100 16,396.4 100 15,612.7 100 15,010.0 100 14,475.2 100

Table 22: Value of Lost Production due to Morbidity, Canada, 2005-2010
($'000,000 2010 Constant Dollars)
Year Total Morbidity Cost
2010 18,164.1
2009 17,264.8
2008 16,741.3
2007 16,312.9
2006 16,028.0
2005 15,760.4

Appendix 1: Mapping of CCHS Disease Categories to EBIC Diagnostic Categories

  • Infectious and Parasitic Diseases
    • Own Infectious Disease (lop_020)
    • Stomach Flu (lop_084)
    • Other Infectious Disease (lop_086)
  • Respiratory Infections
    • Cold (lop_082)
    • Flu or Influenza (lop_083)
    • Respiratory Infection (lop_085)
  • Malignant Neoplasms
    • Cancer (lop_050)
  • Diabetes Mellitus
    • Diabetes (lop_050)
  • Neuropsychiatric Conditions
    • Migraine (lop_050)
    • Mental Illness (lop_050)
    • Neurological Disease (lop_050)
  • Cardiovascular Diseases
    • Cardiovascular Disease (lop_050)
  • Respiratory Diseases
    • Asthma (lop_050)
    • Chronic Bronchitis, Emphysema and Chronic Obstructive Pulmonary Disease (COPD) (lop_050)
  • Digestive Diseases
    • Digestive Diseases (lop_050)
  • Genitourinary Diseases
    • Kidney Disease (lop_050)
  • Musculoskeletal Diseases
    • Arthritis (lop_050)
    • Osteoporosis (lop_050)
    • Back Problems (lop_050)
    • Fibromyalgia, Chronic Fatigue Syndrome or Multiple Chemical Sensitivities (lop_050)
  • Injuries
    • Own Injury (lop_020)
    • Injury (lop_070)
  • Unattributable
    • Other (lop_050)
    • Don't Know (lop_050)
    • Refusal (lop_050)
    • Not Stated (lop_050)
    • Other Reason Related to Physical or Mental Health (lop_020)
    • Other Reason Related to Physical or Mental Health (lop_100)

Note: The text in the bracket indicates the 2010 CCHS LOP module question (65).

Appendix 2: Sampling Variability Guidelines

Type of Estimate Coefficient of variation (CV) in % Guidelines
Source: Statistics Canada (64)
Acceptable: moderate sampling variability 0.0 ≤ CV ≤ 16.5 Estimates can be considered for general unrestricted release.
Marginal: high sampling variability 16.6 ≤ CV ≤ 33.3 Estimates can be considered for general unrestricted release but should be accompanied by a warning cautioning subsequent users of high sampling variability associated with the estimates.
Unacceptable: very high sampling variability CV > 33.3 Statistics Canada recommends not releasing estimates of unacceptable quality. The user is advised that these EBIC morbidity cost estimates do not meet Statistics Canada's quality standards for this statistical program. Conclusions based on these data will be unreliable and most likely invalid. These data and any consequent findings should not be published. If the user chooses to publish these data or findings, then this disclaimer must be published with the data.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: